生命科学资讯

Standard BioTools Completes Sale of SomaLogic to Illumina - citybiz

Standard BioTools Completes Sale of SomaLogic to Illumina - GlobeNewswire

Illumina bets $350M on proteins to help speed drug discovery - Stock Titan

Illumina completes acquisition of SomaLogic - PR Newswire

SomaLogic Partnership Resource Hub - Illumina

A Long-Read Duopoly – PacBio or Oxford Nanopore? - Nanalyze

The Truth About Illumina Inc.: Is This DNA Giant Still Worth Your Money or Is the Hype Over? - AD HOC NEWS

Illumina (ILMN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance

Illumina Launches Multiomic Software Streamlining Scalable and Intuitive Workflows - The Healthcare Technology Report.

Agilus Diagnostics installs Illumina NovaSeq X to revolutionise genomic testing in India - BioSpectrum India

ChIP-Sequencing Market Is Going to Boom |• Illumina • Thermo Fisher Scientific • BGI - openPR.com

Devyser enters Strategic Supply Agreement with Illumina to offer sequencing instruments and products - TradingView

Retirement Systems of Alabama Sells 7,647 Shares of Illumina, Inc. $ILMN - MarketBeat

Illumina, Inc. $ILMN Shares Sold by Mitsubishi UFJ Trust & Banking Corp - MarketBeat

Single-Cell Genome Sequencing Market Is Going to Boom |• 10x Genomics • Illumina - openPR.com

The Analyst Verdict: Illumina In The Eyes Of 15 Experts - Benzinga

Clinical Ambitions: 10x Expands Beyond Research with Trio of Collaborations - GEN - Genetic Engineering and Biotechnology News

Illumina price driven lower by pivotal resistance - Forecast today - 26-01-2026 - Economies.com

Canaccord Genuity raises Illumina stock price target to $150 on solid results - Investing.com

Wealth Enhancement Advisory Services LLC Buys 9,997 Shares of Illumina, Inc. $ILMN - MarketBeat